Skip to main content


Page 5 of 67

  1. Centrosomal protein 55 (CEP55) plays a significant role in specific cancers. However, comprehensive research on CEP55 is lacking in pan-cancer.

    Authors: Guo-Sheng Li, Wei Zhang, Wan-Ying Huang, Rong-Quan He, Zhi-Guang Huang, Xiang-Yu Gan, Zhen Yang, Yi-Wu Dang, Jin-Liang Kong, Hua-Fu Zhou and Gang Chen
    Citation: BMC Pulmonary Medicine 2023 23:166
  2. Digital health technology (DHT) is a growing area in the treatment of chronic diseases. Study results on DHT’s effect on asthma control have been mixed, but benefits have been seen for adherence, self-manageme...

    Authors: Emma M. Genberg, Hilkka T. Viitanen, Mika J. Mäkelä, Hannu J. Kautiainen and Paula M. Kauppi
    Citation: BMC Pulmonary Medicine 2023 23:165
  3. The study investigated the effects and underlying mechanisms of intestinal flora metabolite butyrate on inflammatory ILC2 cells (iILC2s)-mediated lung inflammation in chronic obstructive pulmonary disease (COPD).

    Authors: Min Jiang, Zhiwei Li, Fengbo Zhang, Zheng Li, Dan Xu, Jing Jing, Fengsen Li, Jing Wang and Jianbing Ding
    Citation: BMC Pulmonary Medicine 2023 23:163
  4. NSCLC is a malignant tumor with a high incidence. Ferroptosis presents an essential function in regulating carcinogenesis and tumor progression. However, the ferroptosis-associated prognostic model based on si...

    Authors: Xiaofei Cui, Chang Liu, Penghua Dong, Chao Liu and Yu Bai
    Citation: BMC Pulmonary Medicine 2023 23:162
  5. Robot-assisted bronchoscopy (RAB) is among the newest bronchoscopic technologies, allowing improved visualization and access for small and hard-to-reach nodules. RAB studies have primarily been conducted at ac...

    Authors: Faisal Khan, Joseph Seaman, Tina D. Hunter, Diogo Ribeiro, Balaji Laxmanan, Iftekhar Kalsekar and Gustavo Cumbo-Nacheli
    Citation: BMC Pulmonary Medicine 2023 23:161
  6. Anti-aminoacyl-tRNA synthetase (ARS) antibody-positive patients present with a variety of symptoms, including interstitial lung disease (ILD), which is termed anti-synthetase syndrome (ASS). But it is rare tha...

    Authors: Ippei Miyamoto, Tetsuo Shimizu, Ryo Kusahana, Masayuki Nomoto, Daishi Fujiwara, Tsukasa Nishizawa, Kentaro Hayashi, Yoshiko Nakagawa and Yasuhiro Gon
    Citation: BMC Pulmonary Medicine 2023 23:159
  7. We aimed to determine the clinical. outcomes of various immune checkpoint inhibitor (ICI) combinations for the treatment of non-small cell lung cancer (NSCLC) patients with epidermal growth factor receptor (EG...

    Authors: Jinfei Si, Yue Hao, Jingwen Wei, Jing Xiang, Chunwei Xu, Qiuping Shen and Zhengbo Song
    Citation: BMC Pulmonary Medicine 2023 23:158
  8. Multisystem inflammatory syndrome in children (MIS-C) is a relatively new and rare complication of COVID-19. This complication seems to develop after the infection rather than during the acute phase of COVID-1...

    Authors: Tidarat Sriboonyong, Poomiporn Katanyuwong and Jarin Vaewpanich
    Citation: BMC Pulmonary Medicine 2023 23:157
  9. Alpha-1 antitrypsin deficiency (AATD) is an underrecognized genetic disorder associated mainly with pulmonary emphysema and Chronic Obstructive Pulmonary Disease (COPD). All individuals with COPD regardless of...

    Authors: Abraham Alí-Munive, Prada Leidy, Nadia Juliana Proaños, John Pedrozo-Pupo, Angela Giraldo, Diana Cano, Claudia Diaz-Bossa, Ricardo Mosquera, Hector Paul, Mauricio Gonzalez-García, Carlos Aguirre-Franco, José Luis López-Campos and Alejandro Casas-Herrera
    Citation: BMC Pulmonary Medicine 2023 23:156
  10. The antifibrotic drug nintedanib is used for the treatment of idiopathic pulmonary fibrosis (IPF). We analysed the effect of nintedanib on antifibrotic treatment outcome in real-world cohorts of Czech EMPIRE r...

    Authors: Marianna Štefániková, Martina Doubková, Petra Ovesná, Martina Šterclová, Ladislav Lacina, Monika Žurková, Martina Plačková, Vladimír Bartoš, Ivana Janíčková, Radka Bittenglová, Jan Anton, Ľubica Sýkorová, Vladimíra Lošťáková, Pavlína Musilová, Hana Šuldová, Radka Mokošová…
    Citation: BMC Pulmonary Medicine 2023 23:154
  11. Fiberoptic bronchoscopy (FOB) and bronchoscopic biopsy are the established methods for diagnosing and treating sputum crust. However, sputum crust in concealed locations can sometimes be missed or undiagnosed,...

    Authors: Kun Qian, Yiyong Wei, Xingkui Liu, Zhengfu Li, Song Cao, Dan Wen, Junhua Shi, Yu Zhang and Yinan Zhang
    Citation: BMC Pulmonary Medicine 2023 23:153
  12. Long term macrolide treatment has been found beneficial in bronchiectasis (BE) -pathogical bronchial dilatation- possibly due to a combined anti-bacterial and immunomodulatory effect. The exact mechanism of in...

    Authors: L. C. Terpstra, J. Altenburg, H. J. Doodeman, Y. S. Sabogal Piñeros, R. Lutter, H. G. M. Heijerman and W. G. Boersma
    Citation: BMC Pulmonary Medicine 2023 23:151
  13. Management strategies of chronic obstructive pulmonary disease (COPD) need to be tailored to the forced expiratory volume in one second (FEV1), exacerbations, and patient-reported outcomes (PROs) of individual pa...

    Authors: Chee-Shee Chai, Diana-Leh-Ching Ng, Sumastika Bt Mos, Muhammad Amin B Ibrahim, Seng-Beng Tan, Yong-Kek Pang and Chong-Kin Liam
    Citation: BMC Pulmonary Medicine 2023 23:150
  14. Radiotherapy is an essential treatment for chest cancer. Radiation-induced pulmonary fibrosis (RIPF) is an almost irreversible interstitial lung disease; however, its pathogenesis remains unclear.

    Authors: Zhiyong Sun, Yutao Lou, Xiaoping Hu, Feifeng Song, Xiaowei Zheng, Ying Hu, Haiying Ding, Yiwen Zhang and Ping Huang
    Citation: BMC Pulmonary Medicine 2023 23:149
  15. The purpose of this study was to collect pilot efficacy data on a novel treatment for refractory chronic cough (RCC), which we call cough desensitization treatment (CDT).

    Authors: Laurie J. Slovarp, Jane E. Reynolds, Sophia Tolbert, Sarah Campbell, Shannon Welby and Paige Morkrid
    Citation: BMC Pulmonary Medicine 2023 23:148
  16. Recent studies have indicated some differences in the prognosis of patients with stage III-N2 lung adenocarcinoma, and the prognosis of patients with skip N2 lymph node metastasis (SKN2) is good. This study gr...

    Authors: Shize Wang, Shaonan Xie, Yaqing Han, Maogang Gao, Xin Su and Qingyi Liu
    Citation: BMC Pulmonary Medicine 2023 23:147
  17. Diabetes mellitus is a major cause of high mortality and poor prognosis in patients with pulmonary infections. However, limited data on the application of metagenomic next-generation sequencing (mNGS) are avai...

    Authors: Siqin Zhang, Jing Ou, Yuxue Tan, Bin Yang, Yaoyao Wu and Lin Liu
    Citation: BMC Pulmonary Medicine 2023 23:142
  18. Although cases of respiratory bacterial infections associated with coronavirus disease 2019 (COVID-19) have often been reported, their impact on the clinical course remains unclear. Herein, we evaluated and an...

    Authors: Kensuke Nakagawara, Hirofumi Kamata, Shotaro Chubachi, Ho Namkoong, Hiromu Tanaka, Ho Lee, Shiro Otake, Takahiro Fukushima, Tatsuya Kusumoto, Atsuho Morita, Shuhei Azekawa, Mayuko Watase, Takanori Asakura, Katsunori Masaki, Makoto Ishii, Akifumi Endo…
    Citation: BMC Pulmonary Medicine 2023 23:146
  19. Maintaining correct inhaler technique is crucial in the management of chronic obstructive pulmonary disease (COPD). We aimed to investigate the inhaler technique in patients with COPD, to compare it immediatel...

    Authors: Chonnipha Iamthanaporn, Apiradee Wisitsartkul and Benjamas Chuaychoo
    Citation: BMC Pulmonary Medicine 2023 23:144
  20. Accurate risk stratification in pulmonary arterial hypertension (PAH), a devastating cardiopulmonary disease, is essential to guide successful therapy. Machine learning may improve risk management and harness ...

    Authors: Thomas Sonnweber, Piotr Tymoszuk, Regina Steringer-Mascherbauer, Elisabeth Sigmund, Stephanie Porod-Schneiderbauer, Lisa Kohlbacher, Igor Theurl, Irene Lang, Günter Weiss and Judith Löffler-Ragg
    Citation: BMC Pulmonary Medicine 2023 23:143
  21. Small airway dysfunction (SAD) is a widespread but less typical clinical manifestation of respiratory dysfunction. In lung diseases, SAD can have a higher-than-expected impact on lung function. The aim of this...

    Authors: Yifan Zhang, Haihua Zhang, Xuan Su, Ying Wang, Guizhou Gao, Xiaodong Wang and Tao Zhang
    Citation: BMC Pulmonary Medicine 2023 23:141
  22. Work environments are potential areas for spreading respiratory infections. We hypothesized that certain occupations increase susceptibility to respiratory infections among adults with asthma. Our objective wa...

    Authors: Maritta S. Jaakkola, Taina K. Lajunen, Aino K. Rantala, Rachel Nadif and Jouni J. K. Jaakkola
    Citation: BMC Pulmonary Medicine 2023 23:140
  23. Pulmonary Tuberculosis (PTB) is an important public health problem in Malaysia. In this country, limited research has been carried out on the impact of the disease on the health-related quality of life (HRQoL)...

    Authors: Syafiq Sidqi Saidi and Rosliza Abdul Manaf
    Citation: BMC Pulmonary Medicine 2023 23:139
  24. The use of antibiotics in mild to severe acute exacerbations of chronic obstructive pulmonary disease (COPD) remains controversial.

    Authors: Anna Vanoverschelde, Chloë Van Hoey, Franky Buyle, Nadia Den Blauwen, Pieter Depuydt, Eva Van Braeckel and Lies Lahousse
    Citation: BMC Pulmonary Medicine 2023 23:138
  25. For interpretation of pulmonary function tests (PFTs), reference values based on sex, age, height and ethnicity are needed. In Norway, the European Coal and Steel Community (ECSC) reference values remain widel...

    Authors: Henrik Mangseth, Liv Ingunn Bjoner Sikkeland, Michael Thomas Durheim, Mariann Ulvestad, Ole Henrik Myrdal, Johny Kongerud and May B Lund
    Citation: BMC Pulmonary Medicine 2023 23:137
  26. In the current context of the SARS COVID-19 pandemic, where the main cause of death is respiratory failure, and since early recognition would allow timely measures to be implemented and probably improve outcom...

    Authors: Germán Devia Jaramillo, Luis Carlos Venegas Sanabria and Carolina Buitrago
    Citation: BMC Pulmonary Medicine 2023 23:135
  27. Volatile organic compounds (VOCs) produced by human cells reflect metabolic and pathophysiological processes which can be detected with the use of electronic nose (eNose) technology. Analysis of exhaled breath...

    Authors: B. F.M. van Raaij, J. D. Veltman, J. F. Hameete, J. L. Stöger and J. J.M. Geelhoed
    Citation: BMC Pulmonary Medicine 2023 23:134
  28. Sepsis can result in acute lung injury (ALI). Studies have shown that pharmacological inhibition of ferroptosis can treat ALI. However, the regulatory mechanisms of ferroptosis in sepsis-induced ALI remain unc...

    Authors: Wen Hu, Zhen Wu, Mei Zhang, Shilin Yu and Xiaohua Zou
    Citation: BMC Pulmonary Medicine 2023 23:133
  29. This study analysed the performance of radiomics features extracted from computed tomography (CT) images with different reconstruction parameters in differentiating malignant and benign pulmonary nodules.

    Authors: Rui Zhang, Jie Shi, Siyun Liu, Bojiang Chen and Weimin Li
    Citation: BMC Pulmonary Medicine 2023 23:132
  30. Autoimmune rheumatic diseases (ARD) are groups of diseases that are commonly associated with cardiac and pulmonary manifestations and may affect the morbidity and mortality of the patients. The study aimed to ...

    Authors: Mai M. El-Kalashy, Samah A. Elbeltagy, Enas S. Zahran, Maha M. Salman, Shrief R. Abd Elrahman, Mai M. Abdalraouf and Amal A. El-Koa
    Citation: BMC Pulmonary Medicine 2023 23:131
  31. Eosinophilic granulomatosis with polyangiitis (EGPA) is a form of anti-neutrophil cytoplasmic antibody (ANCA) associated vasculitis characterized by eosinophil-rich granulomatous inflammation and small-to-medi...

    Authors: Isao Suzaki, Akihiko Tanaka, Ryo Yanai, Yuki Maruyama, Sawa Kamimura, Kojiro Hirano and Hitome Kobayashi
    Citation: BMC Pulmonary Medicine 2023 23:130
  32. Recent studies have shown an association between baseline arterial carbon dioxide pressure (PaCO2) and outcomes in patients with acute respiratory distress syndrome (ARDS). However, PaCO2 probably varies througho...

    Authors: Rui Zhang, Hui Chen, Ran Teng, Zuxian Li, Yi Yang, Haibo Qiu and Ling Liu
    Citation: BMC Pulmonary Medicine 2023 23:129
  33. Pulmonary hypertension (PH) is a common complication in patients with chronic obstructive pulmonary disease (COPD) and is closely associated with poor prognosis. However, studies on the predictors of PH in COP...

    Authors: Lixia Wang, Faping Wang, Yajun Tuo, Huajing Wan and Fengming Luo
    Citation: BMC Pulmonary Medicine 2023 23:127

    The Correction to this article has been published in BMC Pulmonary Medicine 2023 23:192

  34. Some patients with connective tissue disease (CTD)-associated interstitial lung disease (ILD) progress to pulmonary fibrosis over their disease course despite initial improvement, potentially indicating a poor...

    Authors: Hideaki Yamakawa, Tamiko Takemura, Shintaro Sato, Makiko Takatsuka, Hiroki Ohta, Tomotaka Nishizawa, Tomohiro Oba, Rie Kawabe, Keiichi Akasaka, Masanobu Horikoshi, Masako Amano, Kazuyoshi Kuwano and Hidekazu Matsushima
    Citation: BMC Pulmonary Medicine 2023 23:126
  35. Intravascular large B-cell lymphoma (IVLBCL) is the proliferation of neoplastic B lymphocytes in the vascular space. Since conventional computed tomography (CT) shows nonspecific findings, differentiation betw...

    Authors: Daisuke Yamada, Ryosuke Imai, Masaki Matsusako and Yasuyuki Kurihara
    Citation: BMC Pulmonary Medicine 2023 23:125
  36. Pulmonary tumor thrombotic microangiopathy is a rapidly progressive and fatal disease in which tumor cells embolize to the pulmonary microvasculature. This condition is characterized by severe dyspnea and righ...

    Authors: Yoshikazu Utsu, Makio Kawakami, Hironori Arai, Haruka Hisamatsu, Yudai Yano and Jiro Terada
    Citation: BMC Pulmonary Medicine 2023 23:124
  37. In Pakistan, chronic respiratory conditions contribute a large burden of morbidity and mortality. A major reason for this is the lack of availability of local evidence-based clinical practice guidelines (EBCPG...

    Authors: Russell Seth Martins, Hawra Hussain, Maryam Chaudry, Nashia Ali Rizvi, Mohsin Ali Mustafa, Bushra Ayub, Salima Saleem Aamdani, Alina Abdul Rehman, Alina Pervez, Sarah Nadeem, Rameesha Khalid, Akbar Shoukat Ali, Shayan Shahid, Ali Bin Sarwar Zubairi, Adil H. Haider and Muhammad Irfan
    Citation: BMC Pulmonary Medicine 2023 23:123
  38. To investigate the value of preoperative computed tomography (CT) texture features, routine imaging features, and clinical features in the prognosis of non-small cell lung cancer (NSCLC) after radical resection.

    Authors: Xingxing Zheng, Rui Li, Lihua Fan, Yaqiong Ge, Wei Li and Feng Feng
    Citation: BMC Pulmonary Medicine 2023 23:122
  39. Paralysis of medical systems has emerged as a major problem not only in Korea but also globally because of the COVID-19 pandemic. Therefore, early identification and treatment of COVID-19 are crucial. This stu...

    Authors: Seung Min Baik, Kyung Tae Kim, Haneol Lee and Jung Hwa Lee
    Citation: BMC Pulmonary Medicine 2023 23:121
  40. Studies linking early life exposure to air pollution and subsequent impaired lung health have focused on chronic, low-level exposures in urban settings. We aimed to determine whether in utero exposure to an ac...

    Authors: Emily J. Hemstock, Rachel E. Foong, Graham L. Hall, Amanda J. Wheeler, Shyamali C. Dharmage, Marita Dalton, Grant J. Williamson, Caroline Gao, Michael J. Abramson, Fay H. Johnston and Graeme R. Zosky
    Citation: BMC Pulmonary Medicine 2023 23:120
  41. Immune checkpoint inhibitors (ICIs) have been widely used in the treatment of cancer. Moreover, immune-related adverse events (irAEs) have become a new clinical challenge. ICI-associated myocarditis is a rare ...

    Authors: Yue Hu, Cuixia Liu, Shaojun Jin, Zihan Yi, Chao Wang, Xiaohong Pan and Huaqiong Huang
    Citation: BMC Pulmonary Medicine 2023 23:119

Annual Journal Metrics

  • 2022 Citation Impact
    3.1 - 2-year Impact Factor
    3.5 - 5-year Impact Factor
    1.081 - SNIP (Source Normalized Impact per Paper)
    0.999 - SJR (SCImago Journal Rank)

    2022 Speed
    21 days submission to first editorial decision for all manuscripts (Median)
    128 days submission to accept (Median)

    2022 Usage 
    3,093 Altmetric mentions 

Peer-review Terminology

  • The following summary describes the peer review process for this journal:

    Identity transparency: Single anonymized

    Reviewer interacts with: Editor

    Review information published: Review reports. Reviewer Identities reviewer opt in. Author/reviewer communication

    More information is available here

Sign up for article alerts and news from this journal